Series D funding round for Antiva Biosciences raising $31M in November 2021
Series D funding round for Antiva Biosciences raising $31M in November 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$137M
Top Valuation
-
Antiva Biosciences raised $31M in a Series D round.
The round was announced on 11/01/21.